Quantum BioPharma is trading 5.3% down at $3.07 as the stock reverses earlier speculative pre-market gains in the absence of fresh fundamental news.

  • Shares briefly climbed 7.65% to a high of $3.49 during pre-market hours before the current pullback.
  • No company-specific headlines, SEC filings, or analyst calls have been released this morning to explain the volatility.
  • The move appears to be a technical reversal of early momentum rather than a reaction to new fundamental data.